Literature DB >> 33442921

Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome.

K Taylor Wild1,2,3, Tomoki T Nomakuchi1,2, Sarah E Sheppard1,2,4, Karla F Leavens2,5, Diva D De León2,5, Elaine H Zackai1,2.   

Abstract

Rubinstein-Taybi syndrome (RSTS) is an autosomal dominant genetic syndrome characterized by distinct facial features, broad thumbs, growth restriction, microcephaly, intellectual disability, and developmental delay. Pathogenic variants in both CREBBP and EP300 have been associated with RSTS. Here we present a case of a female with hyperinsulinism and features consistent with RSTS, found to have a pathogenic variant in EP300. While there have been a few rare case reports of hyperinsulinism in RSTS, we suggest that hyperinsulinism might be a more prominent feature in EP300 variant RSTS than previously recognized.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  EP300; Rubinstein Taybi; hyperinsulinism; hypoglycemia

Mesh:

Substances:

Year:  2021        PMID: 33442921      PMCID: PMC8621558          DOI: 10.1002/ajmg.a.62085

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome.

Authors:  J H RUBINSTEIN; H TAYBI
Journal:  Am J Dis Child       Date:  1963-06

2.  Genome-wide sequencing expands the phenotypic spectrum of EP300 variants.

Authors:  Gregory Costain; Peter Kannu; Sarah Bowdin
Journal:  Eur J Med Genet       Date:  2017-11-10       Impact factor: 2.708

3.  Transient hypoglycemia with hyperinsulinemia in a newborn infant with Rubinstein-Taybi syndrome.

Authors:  D Wyatt
Journal:  Am J Med Genet       Date:  1990-09

4.  Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.

Authors:  K E Snider; S Becker; L Boyajian; S-L Shyng; C MacMullen; N Hughes; K Ganapathy; T Bhatti; C A Stanley; A Ganguly
Journal:  J Clin Endocrinol Metab       Date:  2012-12-28       Impact factor: 5.958

5.  Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.

Authors:  Patricia Fergelot; Martine Van Belzen; Julien Van Gils; Alexandra Afenjar; Christine M Armour; Benoit Arveiler; Lex Beets; Lydie Burglen; Tiffany Busa; Marie Collet; Julie Deforges; Bert B A de Vries; Elena Dominguez Garrido; Nathalie Dorison; Juliette Dupont; Christine Francannet; Sixto Garciá-Minaúr; Elisabeth Gabau Vila; Samuel Gebre-Medhin; Blanca Gener Querol; David Geneviève; Marion Gérard; Cristina Giovanna Gervasini; Alice Goldenberg; Dragana Josifova; Katherine Lachlan; Saskia Maas; Bruno Maranda; Jukka S Moilanen; Ann Nordgren; Philippe Parent; Julia Rankin; Willie Reardon; Marlène Rio; Joëlle Roume; Adam Shaw; Robert Smigiel; Amaia Sojo; Benjamin Solomon; Agnieszka Stembalska; Constance Stumpel; Francisco Suarez; Paulien Terhal; Simon Thomas; Renaud Touraine; Alain Verloes; Catherine Vincent-Delorme; Josephine Wincent; Dorien J M Peters; Oliver Bartsch; Lidia Larizza; Didier Lacombe; Raoul C Hennekam
Journal:  Am J Med Genet A       Date:  2016-09-20       Impact factor: 2.802

6.  Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome.

Authors:  Benjamin D Solomon; Dale L Bodian; Alina Khromykh; Gabriela Gomez Mora; Brendan C Lanpher; Ramaswamy K Iyer; Rajiv Baveja; Joseph G Vockley; John E Niederhuber
Journal:  Am J Med Genet A       Date:  2015-02-25       Impact factor: 2.802

7.  The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.

Authors:  Chi Kin Wong; Adam K Wade-Vallance; Dan S Luciani; Paul K Brindle; Francis C Lynn; William T Gibson
Journal:  Diabetes       Date:  2017-12-07       Impact factor: 9.461

8.  Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children.

Authors:  Christine Ferrara; Payal Patel; Susan Becker; Charles A Stanley; Andrea Kelly
Journal:  J Pediatr       Date:  2015-10-17       Impact factor: 4.406

9.  Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.

Authors:  Mark J Hamilton; Ruth Newbury-Ecob; Muriel Holder-Espinasse; Shu Yau; Suzanne Lillis; Jane A Hurst; Emma Clement; William Reardon; Shelagh Joss; Emma Hobson; Moira Blyth; Maryam Al-Shehhi; Sally A Lynch; Mohnish Suri
Journal:  Clin Dysmorphol       Date:  2016-10       Impact factor: 0.816

10.  EP300-related Rubinstein-Taybi syndrome: Highlighted rare phenotypic findings and a genotype-phenotype meta-analysis of 74 patients.

Authors:  Jennifer L Cohen; Samantha A Schrier Vergano; Sarah Mazzola; Alanna Strong; Beth Keena; Carey McDougall; Alyssa Ritter; Dong Li; Emma C Bedoukian; Leah W Burke; Amber Hoffman; Victoria Zurcher; Ian D Krantz; Kosuke Izumi; Elizabeth Bhoj; Elaine H Zackai; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2020-10-11       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.